CardioSignal

CardioSignal Focuses on Developing Solutions for Detecting Heart Disease Using Digital Cardiac Biomarkers. Its technology utilizes gyroscope and accelerometer motion sensors to non-invasively measure cardiac motion, determining the health and function of the heart. Currently, the digital biomarkers generated by CardioSignal’s technology have been validated in clinical studies for atrial fibrillation (A-fib) and heart failure, with ongoing developments for aortic stenosis, coronary artery disease, and pulmonary hypertension. The application is already available as a Class IIa medical device for detecting signs of atrial fibrillation in 15 countries.